(Q40242515)

English

Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signaling

scientific article published on September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signaling (English)

1 reference

Europe PubMed Central

18 September 2017

1 reference

based on heuristic

inferred from title

author name string

Takayuki Ikezoe

1

1 reference

Europe PubMed Central

18 September 2017

Yang Yang

2

1 reference

Europe PubMed Central

18 September 2017

Chie Nishioka

3

1 reference

Europe PubMed Central

18 September 2017

Kentaro Bandobashi

4

1 reference

Europe PubMed Central

18 September 2017

Hajime Nakatani

5

1 reference

Europe PubMed Central

18 September 2017

Takahiro Taguchi

6

1 reference

Europe PubMed Central

18 September 2017

H Phillip Koeffler

7

1 reference

Europe PubMed Central

18 September 2017

Hirokuni Taguchi

8

1 reference

Europe PubMed Central

18 September 2017

publication date

1 September 2006

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

97

1 reference

Europe PubMed Central

18 September 2017

945-951

1 reference

Europe PubMed Central

18 September 2017

9

1 reference

Europe PubMed Central

18 September 2017

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Lost in translation: dysregulation of cap-dependent translation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Upstream and downstream of mTOR

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

STI571 (Glivec) inhibits the interaction between c-KIT and heat shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00263.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2006.00263.X

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40242515&oldid=1890695601"